checkAd
    Startseite > Aktien > Alterity Therapeutics > Nachrichten
    Alterity Therapeutics Aktie
    1,9500
     
    USD
    -2,50 %
    -0,0500 USD
    Letzter Kurs 02:00:00 NYSE
    1,8100
     
    USD
    200 STK
    Geldkurs 28.05.24
    2,1000
     
    USD
    200 STK
    Briefkurs 28.05.24
    ISIN: US02155X2053 · WKN: A3D4GD · SYM: ATHE · Australien

    Neueste Nachrichten

    Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
    08.05.24 · globenewswire · Alterity Therapeutics
    Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
    30.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
    29.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
    17.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
    10.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
    26.03.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
    20.02.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
    06.02.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
    29.01.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
    22.01.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
    21.12.23 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
    27.11.23 · globenewswire · Alterity Therapeutics